Results 41 to 50 of about 3,630,045 (162)

Isolated eyeball metastasis of non-seminomatous germ cell testicular tumor [PDF]

open access: yesVojnosanitetski Pregled, 2011
Introduction. Testicular tumors most frequently metastasize to regional lymph nodes. Non-seminomatous tumor metastasis of testicle (NSGCTT) to the eyeball is rare. Case report.
Bojanić Nebojša   +5 more
doaj   +1 more source

Modeling and optimization of combined cytostatic and cytotoxic cancer chemotherapy

open access: yes, 2010
Objectives: This study extends a previous mathematical model of cancer cytotoxic chemotherapy, which considered cycling tumor cells and interactions with the immune system, by incorporating a different type of drug: a cytostatic agent.
Aguilar, Soraya   +5 more
core   +1 more source

Risk factors, management and prevention of Chemotherapy-Induced Nausea and Vomiting: scoping review

open access: yes, 2022
OBJECTIVE To identify and synthesize scientific evidence on risk factors, management and prevention of inappetence, nausea and vomiting induced by outpatient anticancer therapy. QUESTION FORMULATION P (Population) – Patients on antineoplastic therapy. C (
Patrícia Peres de Oliveira
core   +1 more source

Nursing care for hodgkin's lymphoma patients subject to chemotherapy: an integrative review

open access: yesOnline Brazilian Journal of Nursing, 2008
The high occurrence rates of Hodgkin’s Lymphomas and the treatment-associated complications as well as the complication of the disease itself evidence the need for a technical-scientific training of nurses in order to provide health care to this ...
Christiane Inocencio Vasques   +3 more
doaj   +2 more sources

Autologous stem cell transplantation in the treatment of multiple myeloma single center experience [PDF]

open access: yesVojnosanitetski Pregled, 2011
Background/Aim. In comparison to standard therapy autologous stem cell transplant (ASCT) with high doses melphalane has improved treatment of multiple myeloma (MM) patients. The aim of this study was to evaluate the results of treatment of MM patients
Marjanović Slobodan   +9 more
doaj   +1 more source

New insight into hyperthermic intraperitoneal chemotherapy: induction of oxidative stress dramatically enhanced tumor killing in in vitro and in vivo models

open access: yes, 2012
BACKGROUND: The aim of hyperthermic intraperitoneal chemotherapy (HIPEC) is to eradicate microscopic residual tumor after radical surgical tumor excision in patients with peritoneal carcinomatosis.
Lehmann, Kuno   +29 more
core   +1 more source

Dental Caries in Children and Adolescents During and After Antineoplastic Chemotherapy

open access: yes, 2018
Objective: To assess caries incidence, intensity, and treatment in children and adolescents under/after antineoplastic treatment. Study design: Patients with permanent and mixed dentition were divided into three groups of 60 patients each (5–18 years ...
Agnieszka Brożyna   +4 more
core   +1 more source

Advance of second-line chemotherapy in advanced non-small cell lung cancer

open access: yesChinese Journal of Lung Cancer, 2008
There is a temporal disease-free period after 1st line chemotherapy in advanced non-small cell lung cancer (NSCLC), most of patients need 2nd line chemotherapy.
Li ZHANG
doaj  

Three-year post-recurrence survival outcome by leukopenia grade 2+ during systemic chemotherapy in recurrent cervical cancer [PDF]

open access: yesObstetrics & Gynecology Science
Objective This study aimed to evaluate the association between grade ≥2 chemotherapy-induced leukopenia (CIL) and 3-year post-recurrence survival (PRS) in patients with recurrent cervical cancer (CC) undergoing systemic chemotherapy. Methods We conducted
Pornpawee Wangsatidtongbai   +2 more
doaj   +1 more source

Gastrointestinal and liver infections in children undergoing antineoplastic chemotherapy in the years 2000

open access: yes, 2016
AIM: To review gastrointestinal and liver infections in children undergoing antineoplastic chemotherapy. To look at gut microflora features in oncology children.
RUBERTO, ELIANA   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy